Eiko Lifesciences Ltd — Important, 30-01-2026: Company Update

Eiko Lifesciences Limited has released its unaudited financial results for the quarter and nine-month period ended 31st December, 2025, approved by its Board of Directors on January 29, 2026. For the quarter, standalone total income was ₹10.13 Cr with a net profit after tax of ₹0.74 Cr, and basic EPS of ₹0.69. On a consolidated basis, total income reached ₹12.30 Cr, yielding a net profit after tax of ₹1.74 Cr, and basic EPS of ₹0.83.